Mingfeng Medical receives new financing | Domestic medical equipment enterprises have the opportunity to coexist
Medical Network July 18th As people's living standards and health awareness increase, the consumption of health care products and services is increasing, and the medical device market has become an investment field favored by capital.
Recently, the reporter of "Daily Economic News" learned from Mingfeng Medical System Co., Ltd. (hereinafter referred to as Mingfeng Medical) that the company has completed a new round of financing recently, and the company's valuation is about 2 billion yuan. According to the disclosure, Mingfeng Medical is operated by Mingfeng Group. , China Advanced Manufacturing Investment Fund, Zhejiang Talent Fund and other investment operations management, focusing on the development, production and sales of CT, PET/CT products, etc., currently in Dalian, China, and Solon, Ohio, USA. Dayton has R&D and production centers.
In fact, not only Mingfeng Medical, but recently, the capital layout medical device industry has appeared frequently.
July 13, Fosun medicine (02196, HK) Announced that its holding subsidiary, Fosun Industrial (Hong Kong) Co., Ltd., intends to participate in the subscription of the D-round preferred shares issued by BNI, a US high-tech innovative company. It is reported that BNI was established in 2011 and is dedicated to ultrasonic imaging products. R&D, production and sales. It is one of the world's leading R&D companies for intelligent handheld ultrasound imaging.
According to relevant analysis data of BMI Research, a research institute of Fitch, an internationally renowned rating agency, the global 2017 medical instruments The market size will reach 354 billion US dollars, and will grow to 432 billion US dollars by the end of 2021. It is worth noting that in this incremental market, in addition to cross-border mergers and acquisitions, domestic medical equipment enterprise It is also constantly exerting efforts to gain a share in the high-end medical device market.
'The original CT suppliers of GPS are not willing to cooperate with us. Later, we see that our CT growth is very fast. They are willing to pick up our orders. At present, we have more than 300 suppliers. 'Wang Yao, Chairman of Mingfeng Medical Board of Directors According to the reporter of Daily Economic News, Mingfeng Medical has sales of about 300 million yuan in the past three years. In 2018, the company's output value is expected to reach 700 million yuan, and sales are expected to be more than 500 million yuan.
However, for domestic medical device companies, there are still no small challenges. health Investors in the industry told reporters that compared with imported equipment, domestic high-end medical equipment should be sold to the top three hospital It is still difficult, on the one hand because of the quality of the instrument itself, and on the other hand, the consciousness of the hospital.
'Innovative medical equipment research and development in China. After the listing, although the price has advantages over imports, it may not be well promoted and applied. This is facing a series of problems. The biggest bottleneck we encounter is sales. Now we are fully exploiting The domestic market, and established production bases in Guangdong, Sichuan, etc.. Pan Huasu, chairman of Mingfeng Medical, said that in order to expand the market, Mingfeng Medical is currently adding the 'One Belt, One Road' along the line and the domestic dimethyl hospital and the following CT market.
For the entire medical device sector, the Industrial Securities Research Report believes that the product market has a large growth rate, the product has certain barriers, and the leading enterprises with large import substitution space can get better development. In the medium and long-term space, the last real The core competitiveness of being able to grow into a large company is to continuously develop a complete line of high barrier products, enhance product strength, and superimpose certain sales capabilities.
